Quantification of influenza virus mini viral RNAs using Cas13
RNA · 2025
DOI: 10.1261/rna.080174.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, 2025. Verfasst von Caitlin H Lamb und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA. Hauptthemen laut MEDLINE: RNA, Viral, CRISPR-Cas Systems, Influenza A virus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Influenza A virus (IAV) RNA synthesis produces full-length and deletion-containing RNA molecules, which include defective viral genomes (DVG) and mini viral RNAs (mvRNA). Sequencing approaches have shown that DVG and mvRNA species may be present during infection, and that they can vary in size, segment origin, and sequence. Moreover, a subset of aberrant RNA molecules can bind and activate host–pathogen receptor retinoic acid-inducible gene I (RIG-I), leading to innate immune signaling and the expression of type I and III interferons. Measuring the kinetics and distribution of these immunostimulatory aberrant RNA sequences is important for understanding their function in IAV infection. Here, we explored if IAV mvRNA molecules can be detected and quantified using amplification-free, CRISPR-LbuCas13a-based detection. We show that CRISPR-LbuCas13a can be used to measure the copy numbers of specific mvRNAs in samples from infected tissue culture cells. However, to efficiently detect mvRNAs in other samples, promiscuous CRISPR guide RNAs are required that activate LbuCas13a in the presence of multiple mvRNA sequences. One crRNA was able to detect full-length IAV segment 5 without amplification, allowing it to be used for general IAV infection detection nasopharyngeal swabs. Using CRISPR-LbuCas13a, we confirm that mvRNAs are present in ferret upper and lower respiratory tract tissue, as well as clinical nasopharyngeal swab extracts of hospitalized patients. Overall, CRISPR-LbuCas13a-based RNA detection is a useful tool for studying deletion-containing viral RNAs, and it complements existing amplification-based approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA.
- University of Cambridge, Department of Pathology, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom.
- Public Health England, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom.
- Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA aj.te.velthuis@princeton.edu cmyhrvol@princeton.edu.
- Department of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, USA.
- Omenn-Darling Bioengineering Institute, Princeton University, Princeton, New Jersey 08544, USA.
ORCID-Profile: Aartjan J W Te Velthuis
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
- Gates Foundation
- Wellcome Trust
- National Institutes of Health
- Center for Disease Control
- New Jersey Alliance for Clinical and Translational Science
Zitieren
APA
Lamb, C. H., Pitré, E. M., Ajufo, S., Rigby, C. V., Bisht, K., Oade, M. S., Jalal, H., Myhrvold, C., & Te Velthuis, A. J. W. (2025). Quantification of influenza virus mini viral RNAs using Cas13. RNA. https://doi.org/10.1261/rna.080174.124
Vancouver
Lamb CH, Pitré EM, Ajufo S, Rigby CV, Bisht K, Oade MS, et al. Quantification of influenza virus mini viral RNAs using Cas13. RNA. 2025. doi:10.1261/rna.080174.124
BibTeX
@article{Lamb2025,
author = {Lamb, Caitlin H and Pitré, Emmanuelle M and Ajufo, Sean and Rigby, Charlotte V and Bisht, Karishma and Oade, Michael S and Jalal, Hamid and Myhrvold, Cameron and Te Velthuis, Aartjan J W},
title = {Quantification of influenza virus mini viral RNAs using Cas13},
journal = {RNA},
year = {2025},
doi = {10.1261/rna.080174.124}
}
EUVIMED